MSFT vs RMBS
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Microsoft exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust financial stability. While the stock is currently experiencing a severe technical downtrend (0/100) and significant 6-month price depreciation (-28.6%), the current price of $374.33 sits well below the growth-based intrinsic value of $471.41 and the analyst target of $587.31. Exceptional earnings growth (59.8% YoY) and high operating margins (47.09%) suggest that the current price correction presents a value opportunity despite bearish insider sentiment.
RMBS exhibits a stable financial health profile with a Piotroski F-Score of 4/9 and an exceptionally strong balance sheet (Debt/Equity 0.02). However, the stock is severely overvalued, trading at $126.93—over 5x its Graham Number of $24.52 and 6x its growth-based intrinsic value of $19.83. While profitability margins are elite (80.56% gross margin), the divergence between strong revenue growth (18.1%) and stagnant earnings growth (1.6%) suggests diminishing returns. Combined with bearish insider selling and a weak technical trend, the current price appears unsustainable.
Compare Another Pair
Related Comparisons
MSFT vs RMBS: Head-to-Head Comparison
This page compares Microsoft Corporation (MSFT) and Rambus Inc. (RMBS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.